CD274 and cancer: Importantly, Mn‐N/C enhances anti‐tumor immune response and exhibits synergistic therapeutic effects when combined with anti‐PD‐L1 blockade, suggesting that Mn‐N/C‐mediated CDT could be a novel strategy for improving cancer immunotherapy (Figure 7).